MICHAEL LOGUE: Open Payments
NPI 1750338919 · ST LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$567 in 27 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $46 · 2025 $567
Food & beverage: $567
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 6 | $159 |
| Novo Nordisk Inc | 7 | $138 |
| Amgen Inc. | 4 | $65 |
| HEARTFLOW, INC. | 3 | $59 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $40 |
| Merck Sharp & Dohme LLC | 2 | $34 |
| Edwards Lifesciences Corporation | 1 | $33 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
Products named: LEQVIO, REPATHA, FFRct, Rybelsus, LifeVest, Wegovy, VERQUVO, SAPIEN 3 Ultra RESILIA.
Industry payments across MO — which companies pay providers there.
